Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.
Guillermo E UmpierrezKevin M PantaloneCharles M AtissoLaura Fernández LandóHiren PatelPublished in: Diabetes, obesity & metabolism (2019)
In patients with type 2 diabetes, dulaglutide reduces HbA1c by lowering both basal and postprandial hyperglycaemia across various HbA1c levels.
Keyphrases